Bing Hou

Bing Hou serves as Vice President and Head of Discovery Science and Translational Medicine at Antengene since April 2019, with a focus on biologics discovery, non-clinical studies, translational medicine, and biomarker discovery. Prior to this role, Bing Hou was Director of R&D at Abmart from December 2015 to March 2019, specializing in target discovery for ADC and CART programs, antibody discovery, and has authored a paper in Science Advances and holds six patents. Bing Hou earned a PhD in Biomedicine from the University of Leeds, where a first-authored paper was published in Nature, and previously obtained a Master’s degree in Animal Physiology from Beijing Normal University and a Bachelor’s degree in Biology from Shandong University.